Free Trial

ACM Research (ACMR) Financials

ACM Research logo
$23.29 +0.88 (+3.93%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$23.28 -0.01 (-0.04%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for ACM Research

Annual Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Income / (Loss) Attributable to Common Shareholders
104 77 39 38 19 19 6.57 -0.32 1.03
Consolidated Net Income / (Loss)
131 97 51 43 22 19 6.57 -0.87 2.39
Net Income / (Loss) Continuing Operations
131 97 51 43 22 19 6.57 -0.87 2.39
Total Pre-Tax Income
166 116 67 43 19 19 7.38 -0.33 2.98
Total Operating Income
151 96 59 39 21 18 6.47 0.70 3.49
Total Gross Profit
392 276 184 115 70 51 34 17 13
Total Revenue
782 558 389 260 157 108 75 37 27
Operating Revenue
782 558 389 260 157 108 75 37 27
Total Cost of Revenue
391 282 205 145 87 57 40 19 14
Operating Cost of Revenue
391 282 205 145 87 57 40 19 14
Total Operating Expenses
241 180 125 76 48 33 28 17 9.84
Selling, General & Admin Expense
70 41 22 15 12 8.06 7.99 5.89 2.67
Marketing Expense
65 47 40 27 17 12 9.61 5.50 3.91
Research & Development Expense
105 93 62 34 19 13 10 5.14 3.26
Total Other Income / (Expense), net
15 20 8.33 4.35 -2.20 1.15 0.91 -1.03 -0.51
Interest Expense
4.15 2.68 1.66 0.77 0.98 0.75 0.50 1.07 0.52
Interest & Investment Income
10 18 13 5.14 1.55 0.50 0.15 0.05 0.02
Other Income / (Expense), net
9.10 4.75 -3.42 -0.02 -2.77 1.39 1.26 - -
Income Tax Expense
35 19 17 0.13 -2.38 -0.52 0.81 0.55 0.60
Net Income / (Loss) Attributable to Noncontrolling Interest
28 20 11 5.16 2.90 0.56 0.00 -0.55 1.36
Basic Earnings per Share
$1.67 $1.29 $0.66 $0.65 $0.34 $1.12 $0.42 ($0.05) $0.30
Weighted Average Basic Shares Outstanding
62.21M 60.16M 59.24M 57.65M 54.70M 16.80M 15.79M 6.87M 2.18M
Diluted Earnings per Share
$1.53 $1.16 $0.59 $0.58 $0.30 $0.99 $0.37 ($0.05) $0.18
Weighted Average Diluted Shares Outstanding
66.24M 64.87M 65.34M 65.36M 63.55M 19.14M 17.91M 6.87M 3.79M
Weighted Average Basic & Diluted Shares Outstanding
63.13M 61.10M 59.70M 19.58M 18.74M 18.14M 15.70M 12.99M -

Quarterly Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
31 31 24 17 18 26 27 7.15 12 21
Consolidated Net Income / (Loss)
39 39 31 22 23 31 34 8.96 14 27
Net Income / (Loss) Continuing Operations
39 39 31 22 23 31 34 8.96 14 27
Total Pre-Tax Income
56 43 41 26 31 32 41 12 17 38
Total Operating Income
44 44 38 25 23 33 30 8.86 17 32
Total Gross Profit
111 105 97 79 79 89 69 40 54 66
Total Revenue
223 204 202 152 170 169 145 74 109 134
Operating Revenue
223 204 202 152 170 169 145 74 109 134
Total Cost of Revenue
113 99 106 73 91 80 76 34 55 68
Operating Cost of Revenue
113 99 106 73 91 80 76 34 55 68
Total Operating Expenses
67 61 59 54 56 55 38 31 37 34
Selling, General & Admin Expense
21 17 16 16 14 12 6.71 7.76 6.91 5.52
Marketing Expense
18 16 17 14 9.44 17 11 9.34 12 13
Research & Development Expense
28 28 26 24 32 26 20 14 18 16
Total Other Income / (Expense), net
12 -1.51 3.14 1.23 8.05 -1.46 11 2.98 0.17 5.91
Interest Expense
1.23 1.21 0.93 0.78 0.70 0.64 0.65 0.70 0.67 0.42
Interest & Investment Income
3.14 4.28 1.69 1.25 8.30 1.99 6.27 1.75 5.79 3.27
Other Income / (Expense), net
11 -4.58 2.39 0.76 0.46 -2.81 5.19 1.92 -4.95 3.06
Income Tax Expense
17 4.01 9.34 4.37 8.13 0.72 7.64 2.88 2.66 10
Net Income / (Loss) Attributable to Noncontrolling Interest
8.03 7.77 7.19 4.66 5.60 5.32 6.77 1.82 2.37 6.07
Basic Earnings per Share
$0.51 $0.49 $0.39 $0.28 $0.29 $0.43 $0.45 $0.12 $0.20 $0.35
Weighted Average Basic Shares Outstanding
62.21M 62.50M 62.18M 61.37M 60.16M 60.22M 59.90M 59.74M 59.24M 59.36M
Diluted Earnings per Share
$0.47 $0.45 $0.35 $0.26 $0.29 $0.39 $0.41 $0.11 $0.20 $0.32
Weighted Average Diluted Shares Outstanding
66.24M 66.67M 67.06M 66.24M 64.87M 65.45M 64.93M 65.06M 65.34M 65.61M
Weighted Average Basic & Diluted Shares Outstanding
63.13M 62.63M 62.47M 62.01M 61.10M 60.61M 60.02M 59.87M 59.70M 59.46M

Annual Cash Flow Statements for ACM Research

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Net Change in Cash & Equivalents
228 -65 -315 491 -46 91 9.96 7.56 5.72
Net Cash From Operating Activities
152 -75 -62 -40 -14 9.40 6.91 -8.10 -7.35
Net Cash From Continuing Operating Activities
152 -75 -62 -40 -14 9.40 6.91 -8.10 -3.70
Net Income / (Loss) Continuing Operations
131 97 51 43 22 19 6.57 -0.87 2.39
Consolidated Net Income / (Loss)
131 97 51 43 22 19 6.57 -0.87 -2.39
Depreciation Expense
9.97 8.09 5.37 2.35 1.06 0.79 0.42 0.27 0.19
Non-Cash Adjustments To Reconcile Net Income
137 49 118 37 -0.26 4.40 3.24 1.59 -1.99
Changes in Operating Assets and Liabilities, net
-126 -229 -236 -123 -36 -15 -3.32 -9.09 0.49
Net Cash From Investing Activities
-12 -6.75 -266 -11 -70 -5.53 -2.07 -24 -0.81
Net Cash From Continuing Investing Activities
-12 -6.75 -266 -11 -70 -5.53 -2.07 -24 -0.81
Purchase of Property, Plant & Equipment
-82 -62 -91 -9.15 -5.21 -0.97 -1.83 -0.65 -0.80
Acquisitions
-3.49 -2.46 -1.43 -0.56 -0.32 -0.15 -0.24 -1.32 -0.02
Purchase of Investments
-26 -26 -5.28 -1.57 -15 -4.41 0.00 -0.95 0.00
Sale and/or Maturity of Investments
175 110 4.58 0.00 0.56 0.00 0.00 - -
Other Investing Activities, net
-75 -26 -172 0.00 -50 0.00 0.00 -21 0.00
Net Cash From Financing Activities
92 19 46 539 33 87 5.12 39 11
Net Cash From Continuing Financing Activities
92 19 46 539 33 87 5.12 39 11
Repayment of Debt
-42 -57 -11 -42 -22 -14 -13 -11 -7.72
Payment of Dividends
-6.90 -3.95 0.00 - - - - - -
Issuance of Debt
130 74 56 30 52 18 18 11 5.92
Other Financing Activities, net
11 6.14 1.31 5.25 2.75 -0.26 0.53 -0.14 3.31
Effect of Exchange Rate Changes
-4.84 -1.74 -33 3.91 4.57 -0.58 - 0.66 -0.32
Cash Interest Paid
4.15 2.68 1.66 0.77 0.98 0.75 0.50 0.28 0.18
Cash Income Taxes Paid
11 26 3.59 1.13 4.97 1.16 0.00 - -

Quarterly Cash Flow Statements for ACM Research

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
76 10 113 29 -24 -50 -2.85 12 -88 12
Net Cash From Operating Activities
89 12 62 -9.65 -38 -18 11 -30 -0.80 -0.10
Net Cash From Continuing Operating Activities
89 12 62 -9.65 -38 -18 11 -30 -0.80 -0.10
Net Income / (Loss) Continuing Operations
39 39 31 22 23 31 34 8.96 14 27
Consolidated Net Income / (Loss)
39 39 31 22 23 31 34 8.96 14 27
Depreciation Expense
2.89 2.39 2.17 2.52 2.07 2.07 2.24 1.71 1.26 1.55
Non-Cash Adjustments To Reconcile Net Income
48 24 42 23 -17 11 29 26 13 53
Changes in Operating Assets and Liabilities, net
-1.41 -54 -14 -57 -47 -62 -54 -67 -30 -82
Net Cash From Investing Activities
-21 -23 20 12 0.54 -49 -7.58 49 -107 -8.67
Net Cash From Continuing Investing Activities
-21 -23 20 12 0.54 -49 -7.58 49 -107 -8.67
Purchase of Property, Plant & Equipment
-11 -33 -13 -25 -12 -28 -6.74 -15 -71 -15
Acquisitions
-1.50 -0.83 -0.48 -0.67 -0.85 -0.33 -1.13 -0.16 -0.35 -0.63
Purchase of Investments
-17 - -1.37 -7.40 -1.27 -23 -0.73 -0.73 -0.08 -
Sale and/or Maturity of Investments
16 21 47 91 18 12 0.73 79 0.09 4.49
Other Investing Activities, net
-5.92 -11 -13 -45 -3.19 -9.09 0.28 -14 -36 7.95
Net Cash From Financing Activities
15 19 31 27 12 3.60 4.87 -1.46 9.44 41
Net Cash From Continuing Financing Activities
15 19 31 27 12 3.60 4.87 -1.46 9.44 41
Repayment of Debt
-4.84 -33 -2.92 -1.48 -5.85 -50 0.59 -1.70 3.96 -9.68
Issuance of Debt
16 58 33 24 17 57 - 0.00 5.32 -
Other Financing Activities, net
4.61 0.05 1.64 4.80 0.85 0.77 4.28 0.24 0.16 0.40
Effect of Exchange Rate Changes
-7.46 2.97 0.21 -0.55 1.81 13 -11 -4.78 9.93 -20
Cash Interest Paid
1.23 1.21 0.93 0.78 0.70 0.64 0.65 0.70 0.67 0.42
Cash Income Taxes Paid
1.42 0.69 9.11 0.00 9.63 9.23 4.37 2.87 3.40 0.06

Annual Balance Sheets for ACM Research

This table presents ACM Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Total Assets
1,856 1,491 1,236 1,052 341 218 103 68 44
Total Current Assets
1,483 1,176 964 953 261 198 96 63 40
Cash & Equivalents
407 182 248 563 72 58 27 18 10
Restricted Cash
3.87 1.08 0.50 0.52 - 60 0.00 - -
Short-Term Investments
19 21 20 29 28 0.00 - - -
Accounts Receivable
430 326 216 125 66 34 28 29 18
Inventories, net
598 545 393 218 89 45 39 15 12
Prepaid Expenses
7.51 20 16 14 5.89 2.05 1.99 0.55 0.72
Other Current Assets
17 81 70 2.38 - - - 0.05 0.05
Plant, Property, & Equipment, net
269 202 83 14 8.19 3.62 3.71 2.34 2.26
Total Noncurrent Assets
103 113 189 85 72 16 3.31 2.64 1.86
Long-Term Investments
37 28 17 13 6.34 5.93 1.36 1.24 0.00
Intangible Assets
3.46 2.54 1.26 0.48 0.55 0.34 0.27 0.11 0.02
Noncurrent Deferred & Refundable Income Taxes
15 20 6.70 13 11 5.33 1.64 1.29 1.84
Other Noncurrent Operating Assets
48 62 163 59 54 4.08 0.04 0.00 -
Total Liabilities & Shareholders' Equity
1,856 1,491 1,236 1,052 341 218 103 68 44
Total Liabilities
760 565 423 241 133 60 51 28 24
Total Current Liabilities
641 501 396 206 103 54 46 22 17
Short-Term Debt
77 38 58 12 28 14 9.45 5.10 4.77
Accounts Payable
277 256 168 133 54 26 27 13 9.14
Current Deferred Revenue
252 185 158 56 1.34 9.13 - 0.14 0.22
Current Deferred & Payable Income Tax Liabilities
13 6.40 3.47 0.25 0.03 3.13 1.19 0.04 0.04
Other Current Liabilities
22 15 8.07 4.60 19 1.36 8.42 3.08 0.00
Total Noncurrent Liabilities
119 64 27 35 30 6.72 4.58 6.22 6.88
Long-Term Debt
106 54 19 23 18 0.00 - - -
Other Noncurrent Operating Liabilities
13 10 8.43 10 11 6.72 4.58 6.22 6.88
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Total Equity & Noncontrolling Interests
1,096 926 812 812 208 97 52 40 2.49
Total Preferred & Common Equity
905 767 675 676 141 97 52 40 -2.43
Total Common Equity
905 767 675 676 141 97 52 40 -2.44
Common Stock
677 630 604 595 102 83 57 50 7.62
Retained Earnings
260 157 94 64 34 16 -3.39 -9.96 -9.64
Accumulated Other Comprehensive Income / (Loss)
-63 -49 -41 9.11 4.86 -1.68 -0.86 0.12 -0.41
Other Equity Adjustments
31 30 17 8.31 - - - - -
Noncontrolling Interest
191 159 137 135 67 0.00 - - 4.92

Quarterly Balance Sheets for ACM Research

This table presents ACM Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
1,794 1,668 1,557 1,410 1,317 1,313 1,148
Total Current Assets
1,445 1,343 1,229 1,116 997 994 971
Cash & Equivalents
333 324 211 207 257 260 336
Restricted Cash
1.78 0.88 0.81 0.56 0.58 0.46 0.37
Short-Term Investments
20 20 19 22 6.38 13 14
Accounts Receivable
430 350 349 286 236 222 203
Inventories, net
629 603 581 507 471 473 328
Prepaid Expenses
11 19 20 18 19 19 18
Other Current Assets
20 27 48 76 6.00 5.31 71
Plant, Property, & Equipment, net
250 229 219 191 159 150 66
Total Noncurrent Assets
99 96 109 103 161 169 110
Long-Term Investments
34 32 31 22 16 17 19
Intangible Assets
2.84 2.84 2.80 2.16 2.11 1.23 0.87
Noncurrent Deferred & Refundable Income Taxes
13 21 21 16 11 13 6.58
Other Noncurrent Operating Assets
49 40 53 63 132 138 84
Total Liabilities & Shareholders' Equity
1,794 1,668 1,557 1,410 1,317 1,313 1,148
Total Liabilities
725 666 596 532 484 480 374
Total Current Liabilities
610 586 533 482 456 450 346
Short-Term Debt
64 74 61 41 57 59 53
Accounts Payable
302 275 259 225 179 188 139
Current Deferred Revenue
226 211 187 196 201 185 142
Current Deferred & Payable Income Tax Liabilities
6.80 11 11 11 10 8.58 8.56
Other Current Liabilities
11 15 15 9.36 9.49 9.79 3.37
Total Noncurrent Liabilities
115 80 63 50 27 30 28
Long-Term Debt
106 71 53 40 16 18 19
Other Noncurrent Operating Liabilities
8.99 9.18 9.30 10 11 12 7.99
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,069 1,001 961 878 833 833 774
Total Preferred & Common Equity
888 833 796 729 692 692 643
Total Common Equity
888 833 796 729 692 692 643
Common Stock
670 659 647 620 613 606 601
Retained Earnings
229 198 174 152 124 101 91
Accumulated Other Comprehensive Income / (Loss)
-41 -55 -55 -60 -62 -33 -58
Other Equity Adjustments
30 30 30 17 17 17 8.31
Noncontrolling Interest
181 168 165 149 141 141 131

Annual Metrics And Ratios for ACM Research

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Growth Metrics
- - - - - - - - -
Revenue Growth
40.23% 43.44% 49.69% 65.84% 45.66% 44.05% 104.47% 33.37% 0.00%
EBITDA Growth
56.47% 78.24% 48.61% 107.44% -0.96% 145.27% 738.62% -73.59% 0.00%
EBIT Growth
59.15% 80.88% 43.78% 106.56% -2.39% 148.30% 1,003.71% -79.94% 0.00%
NOPAT Growth
49.23% 80.24% 14.86% 59.79% 32.10% 217.08% 1,076.38% -82.46% 0.00%
Net Income Growth
35.54% 91.54% 17.81% 98.00% 11.40% 195.98% 853.90% -136.53% 0.00%
EPS Growth
31.90% 96.61% 1.72% 98.00% 11.40% 167.57% 840.00% -127.78% 0.00%
Operating Cash Flow Growth
302.40% -21.11% -55.12% -195.95% -244.07% 36.10% 185.29% -10.16% 0.00%
Free Cash Flow Firm Growth
191.41% 67.57% -474.56% 27.27% -1,942.83% 376.85% 85.65% 0.00% 0.00%
Invested Capital Growth
3.19% 30.31% 149.86% 63.59% 210.99% 42.53% 27.86% 71.59% 0.00%
Revenue Q/Q Growth
7.29% 12.46% 3.57% 23.59% 15.44% 3.62% 5.15% 0.00% 0.00%
EBITDA Q/Q Growth
22.74% 13.49% -8.60% 40.61% 21.96% 3.06% 0.98% 0.00% 0.00%
EBIT Q/Q Growth
23.72% 13.68% -10.10% 41.67% 22.84% 2.28% 1.71% 0.00% 0.00%
NOPAT Q/Q Growth
11.88% 3.80% -5.27% 27.48% 15.69% 15.42% -16.95% 0.00% 0.00%
Net Income Q/Q Growth
13.69% 10.39% -8.06% 28.11% 29.96% 10.92% -14.10% 0.00% 0.00%
EPS Q/Q Growth
6.25% -2.52% -18.06% 28.11% 29.96% -1.98% -58.43% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
497.80% -99.44% 36.32% -329.58% -321.39% 92.29% 198.15% 42.62% 0.00%
Free Cash Flow Firm Q/Q Growth
353.48% 32.83% -31.23% -1.05% -1,768.86% 113.29% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
-4.63% 11.20% 26.56% 28.46% 43.31% -45.24% -16.33% 0.00% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
50.06% 49.53% 47.22% 44.22% 44.44% 47.11% 46.15% 47.18% 48.70%
EBITDA Margin
21.74% 19.49% 15.68% 15.80% 12.63% 18.57% 10.91% 2.66% 13.43%
Operating Margin
19.31% 17.18% 15.18% 14.90% 13.72% 16.55% 8.67% 1.92% 12.75%
EBIT Margin
20.47% 18.04% 14.30% 14.89% 11.96% 17.84% 10.35% 1.92% 12.75%
Profit (Net Income) Margin
16.78% 17.37% 13.00% 16.52% 13.84% 18.10% 8.81% -2.39% 8.72%
Tax Burden Percent
78.94% 83.34% 75.06% 99.69% 112.35% 102.74% 89.08% 268.31% 80.05%
Interest Burden Percent
103.88% 115.53% 121.13% 111.32% 103.04% 98.73% 95.52% -46.43% 85.44%
Effective Tax Rate
21.06% 16.66% 24.94% 0.31% -12.35% -2.74% 10.92% 0.00% 19.95%
Return on Invested Capital (ROIC)
14.93% 11.50% 10.50% 19.84% 24.77% 45.28% 19.43% 2.38% 18.41%
ROIC Less NNEP Spread (ROIC-NNEP)
9.25% 1.78% 8.89% 18.47% 27.66% 43.45% 14.51% 16.59% 26.02%
Return on Net Nonoperating Assets (RNNOA)
-1.94% -0.36% -4.27% -11.42% -12.91% -26.73% -5.17% -5.27% -6.78%
Return on Equity (ROE)
12.98% 11.14% 6.23% 8.42% 11.86% 18.55% 14.26% -2.89% 11.63%
Cash Return on Invested Capital (CROIC)
11.78% -14.82% -75.17% -28.41% -77.91% 10.21% -5.02% -50.34% 0.00%
Operating Return on Assets (OROA)
9.57% 7.38% 4.86% 5.55% 6.70% 11.96% 9.04% 1.25% 7.85%
Return on Assets (ROA)
7.84% 7.10% 4.42% 6.16% 7.76% 12.13% 7.69% -1.55% 5.37%
Return on Common Equity (ROCE)
10.74% 9.25% 5.18% 6.75% 7.73% 13.23% 14.26% -1.79% -1.38%
Return on Equity Simple (ROE_SIMPLE)
14.51% 12.62% 7.49% 6.35% 15.36% 19.99% 12.56% -2.19% -98.07%
Net Operating Profit after Tax (NOPAT)
119 80 44 39 24 18 5.76 0.49 2.79
NOPAT Margin
15.24% 14.32% 11.40% 14.85% 15.42% 17.00% 7.72% 1.34% 10.21%
Net Nonoperating Expense Percent (NNEP)
5.68% 9.72% 1.60% 1.38% -2.89% 1.83% 4.93% -14.21% -7.61%
Return On Investment Capital (ROIC_SIMPLE)
9.32% 7.84% 4.98% - - - - - -
Cost of Revenue to Revenue
49.94% 50.47% 52.78% 55.78% 55.56% 52.89% 53.85% 52.82% 51.30%
SG&A Expenses to Revenue
8.90% 7.29% 5.78% 5.86% 7.80% 7.50% 10.70% 16.13% 9.77%
R&D to Revenue
13.49% 16.62% 16.00% 13.17% 12.21% 12.00% 13.91% 14.07% 11.91%
Operating Expenses to Revenue
30.76% 32.34% 32.04% 29.32% 30.72% 30.56% 37.48% 45.27% 35.95%
Earnings before Interest and Taxes (EBIT)
160 101 56 39 19 19 7.73 0.70 3.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
170 109 61 41 20 20 8.14 0.97 3.68
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
1.05 1.54 0.68 2.46 10.63 3.45 3.33 2.02 0.00
Price to Tangible Book Value (P/TBV)
1.05 1.55 0.68 2.46 10.67 3.46 3.35 2.03 0.00
Price to Revenue (P/Rev)
1.21 2.12 1.18 6.40 9.58 3.12 2.33 2.21 0.00
Price to Earnings (P/E)
9.13 15.31 11.68 44.06 79.89 17.77 26.49 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
10.96% 6.53% 8.56% 2.27% 1.25% 5.63% 3.78% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.05 1.53 0.64 5.09 10.21 6.03 4.66 2.56 0.00
Enterprise Value to Revenue (EV/Rev)
1.09 2.16 0.99 4.73 9.62 2.66 2.08 1.83 0.00
Enterprise Value to EBITDA (EV/EBITDA)
5.01 11.07 6.34 29.94 76.17 14.31 19.05 68.73 0.00
Enterprise Value to EBIT (EV/EBIT)
5.32 11.96 6.95 31.76 80.46 14.90 20.07 95.34 0.00
Enterprise Value to NOPAT (EV/NOPAT)
7.15 15.06 8.73 31.84 62.40 15.64 26.90 136.20 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
5.59 0.00 0.00 0.00 0.00 30.40 22.45 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
9.06 0.00 0.00 0.00 0.00 69.35 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.17 0.10 0.09 0.04 0.22 0.09 0.18 0.13 0.23
Long-Term Debt to Equity
0.10 0.06 0.02 0.03 0.09 0.00 0.00 0.00 0.00
Financial Leverage
-0.21 -0.20 -0.48 -0.62 -0.47 -0.62 -0.36 -0.32 -0.26
Leverage Ratio
1.66 1.57 1.41 1.37 1.53 1.53 1.85 1.86 2.17
Compound Leverage Factor
1.72 1.81 1.71 1.52 1.58 1.51 1.77 -0.86 1.85
Debt to Total Capital
14.30% 9.04% 8.66% 4.13% 18.01% 8.03% 15.29% 11.33% 18.87%
Short-Term Debt to Total Capital
6.04% 3.74% 6.56% 1.42% 10.93% 8.03% 15.29% 11.33% 18.87%
Long-Term Debt to Total Capital
8.25% 5.30% 2.10% 2.71% 7.08% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
14.96% 15.59% 15.44% 16.00% 26.40% 35.13% 0.00% 0.00% 90.76%
Common Equity to Total Capital
70.74% 75.36% 75.90% 79.87% 55.60% 56.83% 84.71% 88.66% -9.63%
Debt to EBITDA
1.08 0.85 1.26 0.85 2.31 0.69 1.16 5.25 1.30
Net Debt to EBITDA
-1.68 -1.29 -3.43 -13.90 -3.07 -5.51 -2.34 -14.24 -1.45
Long-Term Debt to EBITDA
0.62 0.50 0.31 0.56 0.91 0.00 0.00 0.00 0.00
Debt to NOPAT
1.53 1.15 1.74 0.91 1.89 0.75 1.64 10.40 1.71
Net Debt to NOPAT
-2.39 -1.76 -4.72 -14.78 -2.51 -6.02 -3.30 -28.21 -1.91
Long-Term Debt to NOPAT
0.89 0.68 0.42 0.60 0.74 0.00 0.00 0.00 0.00
Altman Z-Score
2.19 2.55 1.77 5.45 8.10 5.03 3.57 2.82 0.00
Noncontrolling Interest Sharing Ratio
17.31% 17.03% 16.80% 19.85% 34.78% 28.67% 0.00% 38.02% 111.87%
Liquidity Ratios
- - - - - - - - -
Current Ratio
2.31 2.35 2.43 4.63 2.53 3.71 2.08 2.88 2.36
Quick Ratio
1.34 1.06 1.22 3.48 1.61 1.72 1.20 2.15 1.64
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
94 -103 -317 -55 -76 4.12 -1.49 -10 0.00
Operating Cash Flow to CapEx
184.87% -121.73% -68.27% -438.03% -259.97% 968.38% 377.54% -1,244.39% -933.25%
Free Cash Flow to Firm to Interest Expense
22.67 -38.39 -191.77 -72.21 -77.35 5.53 -2.99 -9.68 0.00
Operating Cash Flow to Interest Expense
36.73 -28.10 -37.58 -52.41 -13.80 12.62 13.87 -7.56 -14.03
Operating Cash Flow Less CapEx to Interest Expense
16.86 -51.17 -92.62 -64.37 -19.10 11.32 10.20 -8.17 -15.54
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.47 0.41 0.34 0.37 0.56 0.67 0.87 0.65 0.62
Accounts Receivable Turnover
2.07 2.06 2.28 2.72 3.14 3.48 2.60 1.55 1.54
Inventory Turnover
0.68 0.60 0.67 0.94 1.30 1.36 1.48 1.43 1.20
Fixed Asset Turnover
3.32 3.92 8.02 23.37 26.52 29.35 24.68 15.87 12.10
Accounts Payable Turnover
1.46 1.33 1.36 1.55 2.16 2.14 1.98 1.71 1.54
Days Sales Outstanding (DSO)
176.31 177.21 159.77 133.95 116.30 104.98 140.36 235.17 237.22
Days Inventory Outstanding (DIO)
534.27 608.47 543.62 386.37 279.83 268.15 245.88 256.07 303.24
Days Payable Outstanding (DPO)
249.18 275.25 268.11 236.15 168.91 170.78 184.07 213.84 237.48
Cash Conversion Cycle (CCC)
461.41 510.43 435.28 284.17 227.22 202.34 202.17 277.41 302.98
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
811 786 603 241 148 47 33 26 15
Invested Capital Turnover
0.98 0.80 0.92 1.34 1.61 2.66 2.52 1.77 1.80
Increase / (Decrease) in Invested Capital
25 183 362 94 100 14 7.25 11 0.00
Enterprise Value (EV)
852 1,203 387 1,229 1,507 286 155 67 0.00
Market Capitalization
946 1,184 458 1,663 1,500 336 174 81 0.00
Book Value per Share
$14.44 $12.66 $11.35 $34.66 $7.64 $5.35 $3.27 $2.60 ($1.12)
Tangible Book Value per Share
$14.39 $12.62 $11.33 $34.64 $7.61 $5.33 $3.25 $2.59 ($1.13)
Total Capital
1,279 1,018 889 847 254 171 62 45 25
Total Debt
183 92 77 35 46 14 9.45 5.10 4.77
Total Long-Term Debt
106 54 19 23 18 0.00 0.00 0.00 0.00
Net Debt
-285 -140 -209 -570 -61 -110 -19 -14 -5.35
Capital Expenditures (CapEx)
82 62 91 9.15 5.21 0.97 1.83 0.65 0.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)
489 509 357 166 85 41 32 29 18
Debt-free Net Working Capital (DFNWC)
919 714 626 759 185 159 59 46 28
Net Working Capital (NWC)
842 675 568 747 158 145 50 41 23
Net Nonoperating Expense (NNE)
-12 -17 -6.25 -4.34 2.47 -1.18 -0.81 1.36 0.41
Net Nonoperating Obligations (NNO)
-285 -140 -209 -570 -61 -110 -19 -14 -5.35
Total Depreciation and Amortization (D&A)
9.97 8.09 5.37 2.35 1.06 0.79 0.42 0.27 0.19
Debt-free, Cash-free Net Working Capital to Revenue
62.49% 91.28% 91.88% 64.07% 54.58% 37.93% 43.15% 78.10% 65.51%
Debt-free Net Working Capital to Revenue
117.56% 127.94% 160.97% 292.20% 118.43% 147.55% 79.49% 126.53% 102.48%
Net Working Capital to Revenue
107.68% 121.11% 145.97% 287.58% 100.72% 134.76% 66.84% 112.58% 85.05%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$1.67 $1.29 $0.66 $0.65 $0.34 $0.37 $0.14 ($0.02) $0.10
Adjusted Weighted Average Basic Shares Outstanding
62.21M 60.16M 59.24M 57.65M 54.70M 50.40M 47.37M 20.60M 6.53M
Adjusted Diluted Earnings per Share
$1.53 $1.16 $0.59 $0.58 $0.30 $0.33 $0.12 ($0.02) $0.06
Adjusted Weighted Average Diluted Shares Outstanding
66.24M 64.87M 65.34M 65.36M 63.55M 57.41M 53.74M 20.60M 11.38M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.37 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
63.13M 61.10M 59.70M 58.74M 56.23M 54.41M 42.53M 38.98M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
119 80 44 39 15 12 5.76 0.49 2.79
Normalized NOPAT Margin
15.24% 14.32% 11.40% 14.85% 9.61% 11.58% 7.72% 1.34% 10.21%
Pre Tax Income Margin
21.26% 20.84% 17.32% 16.58% 12.32% 17.61% 9.89% -0.89% 10.89%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
38.57 37.52 33.60 50.56 19.07 25.75 15.51 0.65 6.66
NOPAT to Interest Expense
28.71 29.79 26.78 50.43 24.59 24.53 11.57 0.46 5.33
EBIT Less CapEx to Interest Expense
18.70 14.44 -21.44 38.59 13.76 24.45 11.84 0.05 5.16
NOPAT Less CapEx to Interest Expense
8.85 6.71 -28.27 38.47 19.28 23.23 7.90 -0.15 3.83
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
5.26% 4.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
5.26% 4.08% 0.00% 0.00% 0.00% 14.53% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for ACM Research

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
31.21% 21.00% 40.05% 104.95% 56.92% 26.07% 38.49% 76.02% 14.08% 99.53%
EBITDA Growth
121.67% 29.50% 11.33% 128.10% 99.46% -10.54% 61.38% 206.69% -30.65% 224.01%
EBIT Growth
128.79% 30.45% 12.25% 141.01% 103.27% -12.50% 61.04% 183.42% -34.76% 226.69%
NOPAT Growth
75.94% 23.48% 16.87% 214.07% 23.44% 42.11% 80.49% 202.97% -14.17% 88.81%
Net Income Growth
67.85% 24.77% -6.54% 146.48% 64.27% 14.47% 100.60% 220.42% -23.81% 142.83%
EPS Growth
62.07% 15.38% -14.63% 136.36% 45.00% 21.88% 127.78% 210.00% -25.93% 113.33%
Operating Cash Flow Growth
331.00% 166.83% 442.70% 68.36% -4,712.17% -17,725.00% 133.81% -9.97% 97.80% 97.54%
Free Cash Flow Firm Growth
103.25% 47.60% 21.83% 7.97% 52.40% 25.60% 45.47% 32.57% -348.78% -264.89%
Invested Capital Growth
3.19% 20.33% 22.99% 31.36% 30.31% 48.31% 37.84% 45.90% 149.86% 153.62%
Revenue Q/Q Growth
9.56% 0.74% 33.04% -10.64% 1.04% 16.59% 94.70% -31.59% -18.82% 28.08%
EBITDA Q/Q Growth
36.72% -0.37% 47.84% 10.07% -20.13% -14.35% 202.92% -3.75% -64.18% 54.51%
EBIT Q/Q Growth
37.66% -0.94% 53.83% 9.07% -21.51% -14.76% 230.29% -8.01% -66.21% 56.88%
NOPAT Q/Q Growth
-23.85% 38.16% 37.55% 21.57% -46.55% 30.77% 269.64% -52.22% -38.47% 66.08%
Net Income Q/Q Growth
1.12% 23.16% 42.13% -5.18% -24.83% -7.75% 274.84% -36.80% -47.62% 61.67%
EPS Q/Q Growth
4.44% 28.57% 34.62% -10.34% -25.64% -4.88% 272.73% -45.00% -37.50% 77.78%
Operating Cash Flow Q/Q Growth
643.68% -80.66% 738.31% 70.94% -115.16% -257.06% 137.22% -3,726.10% -697.00% 99.70%
Free Cash Flow Firm Q/Q Growth
105.20% 9.85% 33.60% -4.62% 16.33% -34.50% 21.83% 45.90% -30.79% 1.43%
Invested Capital Q/Q Growth
-4.63% 10.45% -5.35% 3.50% 11.20% 12.89% 1.09% 2.68% 26.56% 4.92%
Profitability Metrics
- - - - - - - - - -
Gross Margin
49.59% 51.40% 47.80% 51.99% 46.43% 52.51% 47.48% 53.85% 49.57% 49.34%
EBITDA Margin
25.69% 20.59% 20.82% 18.73% 15.21% 19.24% 26.19% 16.83% 11.96% 27.11%
Operating Margin
19.68% 21.66% 18.57% 16.58% 13.72% 19.68% 21.05% 11.93% 15.36% 23.66%
EBIT Margin
24.40% 19.42% 19.75% 17.08% 13.99% 18.01% 24.64% 14.52% 10.80% 25.95%
Profit (Net Income) Margin
17.50% 18.96% 15.51% 14.52% 13.68% 18.39% 23.24% 12.07% 13.07% 20.25%
Tax Burden Percent
69.31% 90.61% 77.08% 83.49% 74.13% 97.74% 81.48% 75.69% 84.21% 72.11%
Interest Burden Percent
103.50% 107.76% 101.89% 101.81% 131.89% 104.45% 115.77% 109.81% 143.67% 108.21%
Effective Tax Rate
30.69% 9.39% 22.92% 16.51% 25.87% 2.26% 18.52% 24.31% 15.79% 27.89%
Return on Invested Capital (ROIC)
13.36% 18.38% 14.22% 12.28% 8.17% 16.12% 14.64% 7.29% 11.91% 19.28%
ROIC Less NNEP Spread (ROIC-NNEP)
9.31% 19.08% 13.12% 11.71% 4.75% 16.73% 11.38% 6.53% 11.87% 16.86%
Return on Net Nonoperating Assets (RNNOA)
-1.96% -3.82% -3.14% -2.36% -0.96% -4.75% -3.80% -2.38% -5.70% -5.84%
Return on Equity (ROE)
11.41% 14.56% 11.08% 9.93% 7.22% 11.37% 10.85% 4.91% 6.21% 13.44%
Cash Return on Invested Capital (CROIC)
11.78% -4.77% -6.48% -13.94% -14.82% -25.90% -19.17% -26.40% -75.17% -72.80%
Operating Return on Assets (OROA)
11.40% 8.83% 9.18% 7.57% 5.72% 6.98% 9.51% 5.09% 3.67% 12.05%
Return on Assets (ROA)
8.18% 8.63% 7.21% 6.43% 5.60% 7.13% 8.97% 4.23% 4.44% 9.40%
Return on Common Equity (ROCE)
9.43% 12.09% 9.21% 8.24% 5.99% 9.45% 9.01% 4.08% 5.17% 10.79%
Return on Equity Simple (ROE_SIMPLE)
0.00% 13.00% 12.94% 13.81% 0.00% 12.03% 12.11% 9.68% 0.00% 8.55%
Net Operating Profit after Tax (NOPAT)
30 40 29 21 17 32 25 6.71 14 23
NOPAT Margin
13.64% 19.63% 14.31% 13.84% 10.17% 19.23% 17.15% 9.03% 12.93% 17.06%
Net Nonoperating Expense Percent (NNEP)
4.05% -0.70% 1.10% 0.57% 3.42% -0.61% 3.26% 0.75% 0.04% 2.42%
Return On Investment Capital (ROIC_SIMPLE)
2.38% - - - 1.70% - - - 1.58% -
Cost of Revenue to Revenue
50.41% 48.60% 52.20% 48.01% 53.57% 47.49% 52.52% 46.15% 50.43% 50.66%
SG&A Expenses to Revenue
9.26% 8.36% 7.95% 10.38% 8.10% 7.35% 4.64% 10.45% 6.36% 4.13%
R&D to Revenue
12.42% 13.65% 12.83% 15.72% 19.06% 15.51% 13.88% 18.89% 16.43% 11.73%
Operating Expenses to Revenue
29.90% 29.73% 29.23% 35.41% 32.70% 32.83% 26.43% 41.91% 34.21% 25.68%
Earnings before Interest and Taxes (EBIT)
55 40 40 26 24 30 36 11 12 35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
57 42 42 29 26 32 38 12 13 36
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.05 1.43 1.72 2.22 1.54 1.49 1.13 1.01 0.68 1.15
Price to Tangible Book Value (P/TBV)
1.05 1.43 1.72 2.23 1.55 1.50 1.14 1.01 0.68 1.15
Price to Revenue (P/Rev)
1.21 1.74 2.06 2.78 2.12 2.19 1.70 1.66 1.18 1.97
Price to Earnings (P/E)
9.13 14.05 16.82 20.15 15.31 15.21 11.73 13.38 11.68 17.17
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
10.96% 7.12% 5.95% 4.96% 6.53% 6.58% 8.53% 7.47% 8.56% 5.83%
Enterprise Value to Invested Capital (EV/IC)
1.05 1.45 1.78 2.19 1.53 1.51 1.15 1.01 0.64 1.20
Enterprise Value to Revenue (EV/Rev)
1.09 1.69 1.97 2.81 2.16 2.15 1.56 1.49 0.99 1.52
Enterprise Value to EBITDA (EV/EBITDA)
5.01 8.88 10.60 14.30 11.07 11.11 7.20 7.35 6.34 8.57
Enterprise Value to EBIT (EV/EBIT)
5.32 9.51 11.37 15.40 11.96 12.03 7.73 7.89 6.95 9.25
Enterprise Value to NOPAT (EV/NOPAT)
7.15 11.55 13.84 18.91 15.06 13.83 10.50 10.97 8.73 12.23
Enterprise Value to Operating Cash Flow (EV/OCF)
5.59 48.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
9.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.17 0.16 0.14 0.12 0.10 0.09 0.09 0.09 0.09 0.09
Long-Term Debt to Equity
0.10 0.10 0.07 0.06 0.06 0.05 0.02 0.02 0.02 0.02
Financial Leverage
-0.21 -0.20 -0.24 -0.20 -0.20 -0.28 -0.33 -0.36 -0.48 -0.35
Leverage Ratio
1.66 1.65 1.63 1.60 1.57 1.55 1.47 1.46 1.41 1.59
Compound Leverage Factor
1.71 1.77 1.66 1.63 2.07 1.62 1.71 1.61 2.02 1.72
Debt to Total Capital
14.30% 13.76% 12.64% 10.66% 9.04% 8.39% 8.07% 8.50% 8.66% 8.48%
Short-Term Debt to Total Capital
6.04% 5.20% 6.47% 5.70% 3.74% 4.24% 6.31% 6.50% 6.56% 6.26%
Long-Term Debt to Total Capital
8.25% 8.56% 6.18% 4.97% 5.30% 4.15% 1.75% 2.00% 2.10% 2.22%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
14.96% 14.59% 14.67% 15.30% 15.59% 15.55% 15.60% 15.47% 15.44% 15.50%
Common Equity to Total Capital
70.74% 71.65% 72.68% 74.03% 75.36% 76.06% 76.33% 76.03% 75.90% 76.02%
Debt to EBITDA
1.08 1.23 1.12 0.92 0.85 0.84 0.73 0.91 1.26 1.08
Net Debt to EBITDA
-1.68 -1.58 -1.79 -1.18 -1.29 -1.79 -2.08 -2.51 -3.43 -4.46
Long-Term Debt to EBITDA
0.62 0.77 0.55 0.43 0.50 0.42 0.16 0.21 0.31 0.28
Debt to NOPAT
1.53 1.60 1.47 1.22 1.15 1.04 1.07 1.36 1.74 1.53
Net Debt to NOPAT
-2.39 -2.05 -2.34 -1.56 -1.76 -2.23 -3.04 -3.74 -4.72 -6.36
Long-Term Debt to NOPAT
0.89 1.00 0.72 0.57 0.68 0.52 0.23 0.32 0.42 0.40
Altman Z-Score
2.01 2.27 2.49 2.93 2.38 2.34 2.04 1.83 1.65 2.38
Noncontrolling Interest Sharing Ratio
17.31% 16.95% 16.88% 17.03% 17.03% 16.96% 16.88% 16.76% 16.80% 19.73%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.31 2.37 2.29 2.31 2.35 2.32 2.18 2.21 2.43 2.81
Quick Ratio
1.34 1.28 1.18 1.09 1.06 1.07 1.10 1.10 1.22 1.60
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
5.38 -104 -115 -173 -165 -198 -147 -188 -348 -266
Operating Cash Flow to CapEx
776.06% 36.62% 470.41% -37.96% -310.78% -63.88% 168.43% -204.73% -1.13% -0.65%
Free Cash Flow to Firm to Interest Expense
4.38 -85.78 -123.34 -221.09 -237.41 -309.01 -226.57 -270.65 -519.68 -634.40
Operating Cash Flow to Interest Expense
72.15 9.86 66.08 -12.32 -55.03 -27.85 17.49 -43.88 -1.19 -0.24
Operating Cash Flow Less CapEx to Interest Expense
62.85 -17.07 52.04 -44.79 -72.73 -71.45 7.10 -65.31 -106.64 -36.74
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.47 0.46 0.46 0.44 0.41 0.39 0.39 0.35 0.34 0.46
Accounts Receivable Turnover
2.07 2.04 2.37 2.23 2.06 2.03 2.26 2.39 2.28 2.49
Inventory Turnover
0.68 0.65 0.65 0.61 0.60 0.59 0.61 0.58 0.67 0.79
Fixed Asset Turnover
3.32 3.31 3.58 3.45 3.92 3.85 4.26 4.06 8.02 9.82
Accounts Payable Turnover
1.46 1.40 1.54 1.43 1.33 1.35 1.45 1.30 1.36 1.55
Days Sales Outstanding (DSO)
176.31 179.17 154.29 164.03 177.21 180.03 161.18 152.74 159.77 146.53
Days Inventory Outstanding (DIO)
534.27 561.68 559.92 600.78 608.47 622.16 595.43 626.46 543.62 459.86
Days Payable Outstanding (DPO)
249.18 260.21 236.74 254.52 275.25 271.11 251.68 280.01 268.11 235.19
Cash Conversion Cycle (CCC)
461.41 480.64 477.47 510.29 510.43 531.08 504.93 499.18 435.28 371.20
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
811 850 770 813 786 707 626 619 603 477
Invested Capital Turnover
0.98 0.94 0.99 0.89 0.80 0.84 0.85 0.81 0.92 1.13
Increase / (Decrease) in Invested Capital
25 144 144 194 183 230 172 195 362 289
Enterprise Value (EV)
852 1,230 1,367 1,783 1,203 1,064 717 626 387 572
Market Capitalization
946 1,268 1,430 1,766 1,184 1,087 783 699 458 738
Book Value per Share
$14.44 $14.22 $13.44 $12.97 $12.66 $12.15 $11.56 $11.59 $11.35 $10.85
Tangible Book Value per Share
$14.39 $14.17 $13.39 $12.93 $12.62 $12.11 $11.52 $11.57 $11.33 $10.83
Total Capital
1,279 1,240 1,146 1,075 1,018 959 906 910 889 846
Total Debt
183 171 145 115 92 80 73 77 77 72
Total Long-Term Debt
106 106 71 53 54 40 16 18 19 19
Net Debt
-285 -219 -231 -147 -140 -171 -207 -213 -209 -298
Capital Expenditures (CapEx)
11 33 13 25 12 28 6.74 15 71 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
489 544 487 527 509 445 333 329 357 328
Debt-free Net Working Capital (DFNWC)
919 900 831 757 714 675 598 603 626 679
Net Working Capital (NWC)
842 835 757 696 675 634 541 544 568 626
Net Nonoperating Expense (NNE)
-8.62 1.36 -2.42 -1.03 -5.97 1.43 -8.80 -2.26 -0.15 -4.26
Net Nonoperating Obligations (NNO)
-285 -219 -231 -147 -140 -171 -207 -213 -209 -298
Total Depreciation and Amortization (D&A)
2.89 2.39 2.17 2.52 2.07 2.07 2.24 1.71 1.26 1.55
Debt-free, Cash-free Net Working Capital to Revenue
62.49% 74.65% 70.16% 82.84% 91.28% 89.74% 72.30% 78.20% 91.88% 87.31%
Debt-free Net Working Capital to Revenue
117.56% 123.43% 119.83% 119.15% 127.94% 136.02% 129.64% 143.20% 160.97% 180.75%
Net Working Capital to Revenue
107.68% 114.58% 109.15% 109.51% 121.11% 127.83% 117.23% 129.15% 145.97% 166.65%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.51 $0.49 $0.39 $0.28 $0.29 $0.43 $0.45 $0.12 $0.20 $0.35
Adjusted Weighted Average Basic Shares Outstanding
62.21M 62.50M 62.18M 61.37M 60.16M 60.22M 59.90M 59.74M 59.24M 59.36M
Adjusted Diluted Earnings per Share
$0.47 $0.45 $0.35 $0.26 $0.29 $0.39 $0.41 $0.11 $0.20 $0.32
Adjusted Weighted Average Diluted Shares Outstanding
66.24M 66.67M 67.06M 66.24M 64.87M 65.45M 64.93M 65.06M 65.34M 65.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.29 $0.00 $0.00 $0.00 $0.20 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
63.13M 62.63M 62.47M 62.01M 61.10M 60.61M 60.02M 59.87M 59.70M 59.46M
Normalized Net Operating Profit after Tax (NOPAT)
30 40 29 21 17 32 25 6.71 14 23
Normalized NOPAT Margin
13.64% 19.63% 14.31% 13.84% 10.17% 19.23% 17.15% 9.03% 12.93% 17.06%
Pre Tax Income Margin
25.25% 20.92% 20.12% 17.39% 18.45% 18.81% 28.52% 15.95% 15.52% 28.08%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
44.40 32.78 42.90 33.19 34.19 47.44 54.88 15.52 17.52 82.81
NOPAT to Interest Expense
24.83 33.14 31.09 26.90 24.86 50.66 38.20 9.65 20.98 54.45
EBIT Less CapEx to Interest Expense
35.10 5.85 28.85 0.73 16.48 3.84 44.50 -5.92 -87.92 46.31
NOPAT Less CapEx to Interest Expense
15.53 6.21 17.04 -5.56 7.16 7.06 27.82 -11.78 -84.46 17.95
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
5.26% 0.00% 0.00% 0.00% 4.08% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
5.26% 0.00% 0.00% 0.00% 4.08% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About ACM Research's Financials

When does ACM Research's fiscal year end?

According to the most recent income statement we have on file, ACM Research's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ACM Research's net income changed over the last 8 years?

ACM Research's net income appears to be on an upward trend, with a most recent value of $131.27 million in 2024, rising from $2.39 million in 2016. The previous period was $96.85 million in 2023. View ACM Research's forecast to see where analysts expect ACM Research to go next.

What is ACM Research's operating income?
ACM Research's total operating income in 2024 was $151.00 million, based on the following breakdown:
  • Total Gross Profit: $391.55 million
  • Total Operating Expenses: $240.56 million
How has ACM Research revenue changed over the last 8 years?

Over the last 8 years, ACM Research's total revenue changed from $27.37 million in 2016 to $782.12 million in 2024, a change of 2,757.5%.

How much debt does ACM Research have?

ACM Research's total liabilities were at $759.82 million at the end of 2024, a 34.5% increase from 2023, and a 3,072.8% increase since 2016.

How much cash does ACM Research have?

In the past 8 years, ACM Research's cash and equivalents has ranged from $10.12 million in 2016 to $562.55 million in 2021, and is currently $407.45 million as of their latest financial filing in 2024.

How has ACM Research's book value per share changed over the last 8 years?

Over the last 8 years, ACM Research's book value per share changed from -1.12 in 2016 to 14.44 in 2024, a change of -1,390.5%.



This page (NASDAQ:ACMR) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners